Bank of Montreal’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-49,480
| Closed | -$2.82M | – | 5224 |
|
|
2020
Q3 | $2.82M | Sell |
49,480
-2,949
| -6% | -$182K | ﹤0.01% | 1515 |
|
|
2020
Q2 | $3.36M | Buy |
52,429
+959
| +2% | +$55.5K | ﹤0.01% | 1365 |
|
|
2020
Q1 | $2.88M | Buy |
51,470
+323
| +0.6% | +$18.4K | ﹤0.01% | 1254 |
|
|
2019
Q4 | $2.91M | Buy |
51,147
+35,273
| +222% | +$1.87M | ﹤0.01% | 1671 |
|
|
2019
Q3 | $850K | Buy |
15,874
+13,368
| +533% | +$778K | ﹤0.01% | 2161 |
|
|
2019
Q2 | $151K | Sell |
2,506
-2,565
| -51% | -$161K | ﹤0.01% | 3085 |
|
|
2019
Q1 | $317K | Sell |
5,071
-220
| -4% | -$14.6K | ﹤0.01% | 2509 |
|
|
2018
Q4 | $320K | Sell |
5,291
-244
| -4% | -$14.6K | ﹤0.01% | 2363 |
|
|
2018
Q3 | $324K | Buy |
5,535
+119
| +2% | +$6.07K | ﹤0.01% | 2526 |
|
|
2018
Q2 | $243K | Sell |
5,416
-10
| -0.2% | -$430 | ﹤0.01% | 2668 |
|
|
2018
Q1 | $240K | Buy |
5,426
+55
| +1% | +$2.31K | ﹤0.01% | 2551 |
|
|
2017
Q4 | $232K | Sell |
5,371
-166
| -3% | -$7.46K | ﹤0.01% | 2616 |
|
|
2017
Q3 | $258K | Sell |
5,537
-1,469
| -21% | -$70.3K | ﹤0.01% | 2556 |
|
|
2017
Q2 | $346K | Sell |
7,006
-266
| -4% | -$13.9K | ﹤0.01% | 2421 |
|
|
2017
Q1 | $398K | Buy |
7,272
+699
| +11% | +$37K | ﹤0.01% | 2184 |
|
|
2016
Q4 | $325K | Buy |
6,573
+3,815
| +138% | +$183K | ﹤0.01% | 2297 |
|
|
2016
Q3 | $126K | Sell |
2,758
-1,056
| -28% | -$42.4K | ﹤0.01% | 2657 |
|
|
2016
Q2 | $152K | Buy |
3,814
+13
| +0.3% | +$476 | ﹤0.01% | 2612 |
|
|
2016
Q1 | $132K | Hold |
3,801
| – | – | ﹤0.01% | 2676 |
|
|
2015
Q4 | $164K | Buy |
3,801
+1,065
| +39% | +$53.4K | ﹤0.01% | 2529 |
|
|
2015
Q3 | $119K | Sell |
2,736
-714
| -21% | -$38.5K | ﹤0.01% | 2533 |
|
|
2015
Q2 | $178K | Buy |
3,450
+1,360
| +65% | +$58K | ﹤0.01% | 2460 |
|
|
2015
Q1 | $82K | Sell |
2,090
-681
| -25% | -$26.7K | ﹤0.01% | 2720 |
|
|
2014
Q4 | $107K | Buy |
2,771
+84
| +3% | +$3.21K | ﹤0.01% | 2746 |
|
|
2014
Q3 | $95K | Sell |
2,687
-1,052
| -28% | -$30.9K | ﹤0.01% | 2851 |
|
|
2014
Q2 | $101K | Buy |
3,739
+75
| +2% | +$1.95K | ﹤0.01% | 2837 |
|
|
2014
Q1 | $95K | Sell |
3,664
-44
| -1% | -$1.05K | ﹤0.01% | 2823 |
|
|
2013
Q4 | $80K | Buy |
3,708
+1,759
| +90% | +$36K | ﹤0.01% | 2646 |
|
|
2013
Q3 | $38K | Hold |
1,949
| – | – | ﹤0.01% | 2959 |
|
|
2013
Q2 | $30K | Buy |
+1,949
| New | +$31.4K | ﹤0.01% | 2924 |
|
Other funds holding BSTC
Bank of Montreal's BSTC Position: Q4 2020 in Review
Bank of Montreal sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 49,480 shares — an estimated $2.82M sold.
Bank of Montreal first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $3.36M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Bank of Montreal reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Bank of Montreal sold 49,480 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $2.82M.
- Bank of Montreal first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- Bank of Montreal's BioSpecifics Technologies Corp. position peaked at $3.36M in Q2 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Bank of Montreal's 13F filing for Q4 2020, filed 12 Feb 2021.